United Rheumatology, CreakyJoints launch RA resource during Arthritis Awareness Month
Click Here to Manage Email Alerts
United Rheumatology and CreakyJoints have announced a partnership to launch the Rheumatoid Arthritis Wellness Center, a digital resource that aims to offer support to patients living with RA, according to a press release.
“Our United Rheumatology rheumatologists understand that living with RA can be hard and coping with RA symptoms like pain and fatigue often requires more than just medication,” Andrew Concoff, MD, FACR, chief medical officer at United Rheumatology, said in the release. “That’s why we were inspired to collaborate with CreakyJoints to create a centralized, reliable resource for our patients that will start them on the path of understanding their disease and committing to lifelong management.”
The announcement comes during Arthritis Awareness Month in the United States. In recognition, Healio Rheumatology has compiled five of its most-read stories focusing on various arthritis disease states. Read them below:
‘Large proportion’ of patients with PsA fail to meet treatment targets
A “large proportion” of patients with psoriatic arthritis fail to reach treatment targets despite medication, with residual musculoskeletal and skin disease frequently observed, according to data published in Rheumatology and Therapy. Read more.
All or something: Experts debate LDA vs. remission as a target in rheumatoid arthritis
The 2021 American College of Rheumatology RA recommendations suggest a goal of low disease activity, and not full remission, as the initial target for treatment. This has, among some experts, been controversial. Read more.
Nearly 1 in 6 patients with RA develop interstitial lung disease within 20 years
More than 15% of patients with RA develop interstitial lung disease within 20 years, with the latter condition associated with shorter survival, according to data published in Arthritis Care & Research. Read more.
ACR guidelines: ‘Turn the pyramid upside down’ for biologic DMARDs in JIA
The American College of Rheumatology has released two updated guideline papers for the treatment and management of juvenile idiopathic arthritis. Read more.
FDA approves Skyrizi for adults with active psoriatic arthritis
The FDA has approved AbbVie’s risankizumab-rzaa for the treatment of adults with active PsA, expanding its initial indication from plaque psoriasis only. Read more.
Reference:
United Rheumatology and CreakyJoints Launch the Rheumatoid Arthritis Wellness Center. https://www.businesswire.com/news/home/20220505005712/en/United-Rheumatology-and-CreakyJoints-Launch-the-Rheumatoid-Arthritis-Wellness-Center. May 5, 2022. Accessed May 9, 2022.
Collapse
Read more about
Click Here to Manage Email Alerts